Current Neurovascular Research
Title:Late Onset Alzheimer’s Disease: Novel Clinical Prospects for the Future
Volume: 14 Issue: 2
Author(s): Kenneth Maiese*
Affiliation:
- Laboratory of Cellular and Molecular Signaling Cancer Center, F 1220 New Jersey Health Sciences University 205 South Orange Avenue, Newark, NJ 07101,United States
Export Options
About this article
Cite this article as:
Maiese Kenneth*, Late Onset Alzheimer’s Disease: Novel Clinical Prospects for the Future, Current Neurovascular Research 2017; 14 (2) . https://dx.doi.org/10.2174/1567202614999170313155128
DOI https://dx.doi.org/10.2174/1567202614999170313155128 |
Print ISSN 1567-2026 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5739 |
24
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Toward The Rational Design of Cell Fate Modifiers Notch Signaling as a Target for Novel Biopharmaceuticals
Current Pharmaceutical Biotechnology Mitochondrial DNA Mutations in Cancer: A Review
Current Topics in Medicinal Chemistry Meet the Editorial Board:
Technology Transfer and Entrepreneurship (Discontinued) Do Epigenetic Pathways Initiate Late Onset Alzheimer Disease (LOAD): Towards a New Paradigm
Current Alzheimer Research W-F Substitutions in Apomyoglobin Increase the Local Flexibility of the N-terminal Region Causing Amyloid Aggregation: A H/D Exchange Study
Protein & Peptide Letters Autophagy: A Major Target of Cadmium Nephrotoxicity
Current Chemical Biology Clinical Applications of Mesenchymal Stem Cells in Laryngotracheal Reconstruction
Current Stem Cell Research & Therapy Commentary ( Two Hits with One Shot – A Possibility of Simultaneous Targeting Motor Neuron Loss and Depression in ALS by Upregulating ADAR2 )
CNS & Neurological Disorders - Drug Targets Microglia in Alzheimer’s Disease
Current Alzheimer Research Editorial (Thematic Issue: Emerging Biomarkers for Drug Development in Amyotrophic Lateral Sclerosis)
Current Medicinal Chemistry The Paths to Neurodegeneration in Genetic Parkinson's Disease
CNS & Neurological Disorders - Drug Targets Plant Secondary Metabolites- Potent Inhibitors of Monoamine Oxidase Isoforms
Central Nervous System Agents in Medicinal Chemistry Meet Our Editorial Board Member
Recent Patents on CNS Drug Discovery (Discontinued) Every Cloud Has a Silver Lining: Proneurogenic Effects of Aβ Oligomers and HMGB-1 via Activation of the RAGE-NF-κB Axis
CNS & Neurological Disorders - Drug Targets Epigenetic Regulation of Memory-Therapeutic Potential for Disorders
Current Neuropharmacology Implication of Rho GTPases in Neurodegenerative Diseases
Current Drug Targets Tau Pathology and Future Therapeutics
Current Alzheimer Research Ketogenic Diets in the Treatment of Epilepsy
Current Pharmaceutical Design Antioxidants and Neuroprotection in the Adult and Developing Central Nervous System
Current Medicinal Chemistry Common Themes in RNA Subcellular Transport, Stress Granule Formation and Abnormal Protein Aggregation
Current Chemical Biology